PMID: 21036675

Lay-Son G, Puga A, Astudillo P, Repetto GM
Cystic fibrosis in Chilean patients: Analysis of 36 common CFTR gene mutations.
J Cyst Fibros. 2011 Jan;10(1):66-70. Epub 2010 Oct 30., [PubMed]
Sentences
No. Mutations Sentence Comment
5 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 21036675:5:140
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 21036675:5:80
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21036675:5:96
status: NEW
view ABCC7 p.Gly542* details
Mutations with frequencies greater than 1% were p.F508del (30.3% of alleles), p.R334W (3.3%), p.G542X (2.4%), c.3849+10Kb CNT (1.7%), and p.R553X (1.2%). Login to comment
50 ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21036675:50:124
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 21036675:50:133
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 21036675:50:146
status: NEW
view ABCC7 p.Ile148Thr details
Seven mutations had not been previously reported in the Chilean population (p.1078delT, pG85E, c.3120+1 GNA, c.711+1 GNT, p.R117H, p.A455E, and p.I148T). Login to comment
52 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 21036675:52:107
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 21036675:52:68
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21036675:52:77
status: NEW
view ABCC7 p.Gly542* details
In addition, another 4 mutations had a frequency greater than 1% (p.R334W, p.G542X, c.3849+10Kb CNT, and p.R553X), encompassing 8.5% of the total alleles or 20.2% of detected alleles, while 6 mutations were found in only one family. Login to comment
55 ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 21036675:55:82
status: NEW
view ABCC7 p.Arg334Trp details
Forty-six patients were homozygotes, 44 (15.2%) for p.F508del, and 2 (1.7%) for p.R334W. Login to comment
61 ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 21036675:61:6
status: NEW
view ABCC7 p.Arg553* details
The p.R553X mutation was found in all three zones but was over-represented in the northern area (5.0% or 3/60 alleles), where it was the second most common after p.F508del. Login to comment
70 ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 21036675:70:106
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21036675:70:115
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 21036675:70:128
status: NEW
view ABCC7 p.Arg1162* details
Several other prevalent mutations in our Chilean cohort are common in Southern European countries (i.e: p.R334W, p.G542X, and p.R1162X), and even more prevalent in the Canary Islands (4%; 14.3%-25% and 6.1%, respectively) [14,15], a point of halting for the Spanish expeditions to America, including Columbus' first journey [16]. Login to comment
81 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 21036675:81:673
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 21036675:81:600
status: NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 21036675:81:627
status: NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 21036675:81:512
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 21036675:81:398
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 21036675:81:304
status: NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 21036675:81:807
status: NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Arg347His
X
ABCC7 p.Arg347His 21036675:81:1207
status: NEW
view ABCC7 p.Arg347His details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 21036675:81:699
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 21036675:81:332
status: NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 21036675:81:428
status: NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Ser1251Asn
X
ABCC7 p.Ser1251Asn 21036675:81:1162
status: NEW
view ABCC7 p.Ser1251Asn details
ABCC7 p.Ile148Thr
X
ABCC7 p.Ile148Thr 21036675:81:651
status: NEW
view ABCC7 p.Ile148Thr details
ABCC7 p.Val520Phe
X
ABCC7 p.Val520Phe 21036675:81:1227
status: NEW
view ABCC7 p.Val520Phe details
ABCC7 p.Ser549Arg
X
ABCC7 p.Ser549Arg 21036675:81:1044
status: NEW
view ABCC7 p.Ser549Arg details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 21036675:81:487
status: NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Ser549Asn
X
ABCC7 p.Ser549Asn 21036675:81:915
status: NEW
view ABCC7 p.Ser549Asn details
ABCC7 p.Arg560Thr
X
ABCC7 p.Arg560Thr 21036675:81:966
status: NEW
view ABCC7 p.Arg560Thr details
ABCC7 p.Gln552*
X
ABCC7 p.Gln552* 21036675:81:1247
status: NEW
view ABCC7 p.Gln552* details
ABCC7 p.Glu60*
X
ABCC7 p.Glu60* 21036675:81:1120
status: NEW
view ABCC7 p.Glu60* details
Mutation This study Rios et al. [4] Molina et al. [5] Repetto et al. [6] Perez et al. [13] CFGAC [2] (n=578) (%) (n=72) (%) (n=36) (%) (n=100) (%) (n=4102) (%) (n=43,849) (%) Chile Chile Chile Chile Latin-Americaa Worldwide Unknown 58.0 66.6 61.1 34.0 36.7 22.7 p.F508del 30.6 29.2 30.6 45.0 47.1 66.0 p.R334W 3.1 - - 2.0 0.8 0.1 p.G542X 2.4 0 8.3 7.0 5.0 2.4 c.3849+10Kb CNT 1.7 - - 3.0 0.3 0.2 p.R553X 1.2 4.2 0 1.0 0.4 0.7 p.R1162X 0.9 - - 2.0 1.0 0.3 p.1078delT 0.5 - - 0 b0.1 0.1 p.G85E 0.5 - - - 0.8 0.2 p.W1282X 0.2 - - 5.0 1.0 1.2 c.3120+1 GNA 0.2 - - - 0.3 - c.711+1 GNT 0.2 - - - 0.1 0.1 p.R117H 0.2 - - 0 b0.1 0.3 p.A455E 0.2 - - 0 0 0.1 p.I148T 0.2 - - - - - p.G551D 0 0 0 1.0 0.1 1.6 p.N1303K 0 0 0 0 1.8 1.3 c.621+1 GNT 0 - - 0 0.2 0.7 c.1717-1 GNA 0 - - 0 0.3 0.6 p.I507del 0 - - 0 0.2 0.2 p.R347P 0 - - 0 0 0.2 c.2789+5 GNA 0 - - - 0.2 0.1 c.1898+1 GNA 0 - - - 0.1 0.1 c.2184delA 0 - - - b0.1 0.1 p.S549N 0 - 0 - 0.1 0.1 c.3659delC 0 - - 0 0.1 0.1 p.R560T 0 - - - 0 0.1 c.1811+1.6Kb ANG 0 - - - 0.4 - c.2183AANG 0 - - 0 0.1 - p.S549R 0 - - - 0.1 - c.3272-26 ANG 0 - - - 0.1 - c.3199del6 0 - - - b0.1 - p.E60X 0 - - 0 0 - c.3905insT 0 - - - 0 - p.S1251N 0 - - 0 - - CFTRdele2,3 0 - - - - - p.R347H 0 - - - - - p.V520F 0 - - - - - p.Q552X 0 - - - - - c.394delTT 0 - - - - - c.711+1 GNA 0 - - - - - c.2143delT 0 - - - - - c.3876delA 0 - - - - - a Data from Chilean patients published in Rios et al., Molina et al., and Repetto et al. [4-6] included in this publication were excluded in this table to avoid repetition. Login to comment